 Conformis Incs NASDAQ: CFMS Q4 revenues decreased 8 YY to 15.4 million, missing the consensus of 15.61 million. The decrease is primarily due to deferred and rescheduled elective surgeries due to increased COVID-19 cases associated with the Delta and Omicron variants. 